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Abstract
Background: Studies that ascertain families containing multiple relatives affected by disease can be useful for
identification of causal, rare variants from next-generation sequencing data.
Results: We present the R package SimRVPedigree, which allows researchers to simulate pedigrees ascertained
on the basis of multiple, affected relatives. By incorporating the ascertainment process in the simulation,
SimRVPedigree allows researchers to better understand the within-family patterns of relationship amongst
affected individuals and ages of disease onset.
Conclusions: Through simulation, we show that affected members of a family segregating a rare disease variant
tend to be more numerous and cluster in relationships more closely than those for sporadic disease. We also show
that the family ascertainment process can lead to apparent anticipation in the age of onset. Finally, we use simulation
to gain insight into the limit on the proportion of ascertained families segregating a causal variant. SimRVPedigree
should be useful to investigators seeking insight into the family-based study design through simulation.
Keywords: Pedigree simulation, Family-based study, Rare variant, Ascertainment bias, Anticipation
Background
Family-based studies of pedigrees with multiple disease-
affected relatives are regaining traction for identification
of rare causal variants. These study designs were popu-
lar, for a time, but were eclipsed as genome-wide asso-
ciation studies (GWAS) gained popularity [1]. GWAS
have been effective for identifying population associations
with common variants genome-wide, but have low power
to study rare variants [2]. Family-based studies require
smaller sample sizes than their case/control counterparts
and enjoy increased power to detect effects of rare vari-
ants [2]. Additionally, family-based studies are able to
identify next-generation sequencing (NGS) errors by uti-
lizing familial relationships to identify unlikely calls [2].
Improvements in the cost and technology associated with
NGS have facilitated a revival in family-based studies [1].
Family-based analyses coupled with NGS can uncover
rare variants that are undetected by GWAS [2]. For exam-
ple, analysis of whole exome sequence data was used to
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identify rare variants associated with non-syndromic oral
clefts in large pedigrees ascertained to contain at least
two affected relatives [3], to prioritize rare variants in
large multi-generational pedigrees ascertained for mul-
tiple relatives diagnosed with bipolar disorder [4], and
to identify rare variants segregating in families that con-
tained at least two siblings with an autism spectrum
disorder [5].
Unfortunately, family-based studies do not come
without complication; for example, identifying a suit-
able number of pedigrees with desired criteria may be
time consuming, sometimes requiring years to amass.
In these circumstances, collecting new data to eval-
uate methodology or replicate findings is impractical.
To address this challenge we have created an R pack-
age, entitled SimRVPedigree, which simulates pedi-
grees ascertained to contain a minimum number of
disease-affected relatives. SimRVPedigree models the
affected individuals in an ascertained pedigree as the
result of (1) sporadic disease or (2) a single, rare, disease-
variant segregating in the pedigree. At the individual
level, SimRVPedigree models competing age-specific
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life events contingent on rare-variant status, disease sta-
tus, and age through user supplied age-specific inci-
dence rates of disease, and age-specific hazard rates for
death. In a recursive manner, life events simulated at
the individual level build and shape simulated pedigrees.
Upon specification of user-defined study characteristics,
SimRVPedigree will simulate pedigrees ascertained to
contain multiple affected relatives according the specified
criteria. To our knowledge, this is the only program to
incorporate a competing risk model and account for the
ascertainment process.
Methods
Given a sample of pedigrees we allow for the possibil-
ity that different families may segregate different rare
variants, but assume that within a family genetic cases
are due to a shared rare variant that increases disease
susceptibility. We allow users to choose between two
methods of rare variant introduction to the pedigree.
One option is to assume that all ascertained pedigrees
with genetic cases are segregating a variant that is rare
enough to have been introduced by exactly one founder
[6]. Alternatively, we allow users to simulate the start-
ing founder’s rare variant status with probability equal to
the carrier probability of all causal variants considered
as a group. When this option is selected some ascer-
tained pedigrees may not segregate a causal variant. In
either scenario, we assume that a causal variant is intro-
duced by at most one founder and, when it is intro-
duced, it is transmitted from parent to offspring according
to Mendel’s laws.
Starting at birth and ending with death, we simulate
life events for the starting founder, censoring any events
that occur after the last year of the study. We repeat this
process, recursively, for all descendants of the founder
allowing life events at the individual level to shape suc-
cessive generations of the pedigree. To accomplish this,
we condition on an individual’s age, rare-variant status
and disease status, and simulate waiting times to three
competing life events: reproduction (i.e. producing off-
spring), disease onset, and death. We select the event with
the shortest waiting time, update the individual’s age by
this waiting time, record the event type, and repeat this
process from the new age until the individual dies or the
end of the study is reached.
Simulating life events
To simulate life events SimRVPedigree users are
required to specify:
hazardDF, a data frame of age-specific hazard rates,
where column one represents the age-specific hazard
rates for the disease in the general population,
column two represents the age-specific hazard rates
for death in the unaffected population, and column
three represents the age-specific hazard rates for
death in the affected population, and
partition, a discrete partition of ages over which to
apply hazardDF.
Specifically, partition is a vector of ages, starting
at age 0, such that hazardDF[k,] are the age-specific
hazard rates for an individual whose age is contained in
[partition[k], partition[k+1]). At the user’s dis-
cretion, if the disease of interest is rare, the age-specific
hazard rates for death in the unaffected population may
be approximated by age-specific hazard rates for death in
the general population. In the following subsections, we
detail the procedures to simulate waiting times to onset,
death, and reproductive events.
Disease onset
We model disease onset using a non-homogeneous
Poisson process (e.g. [7]), conditioned on an individual’s
current age, t′, rare-variant status, x, and disease status, δ.
In this context, x = 1 if the individual is a carrier of the
rare variant, and 0 otherwise; and δ = 1 if the individual
has developed disease by age t′, and 0 otherwise. Define κ
to be the relative-risk of disease for individuals who have
inherited the causal variant and λo(t) to be the baseline
age-specific hazard rate of disease for an individual aged
t years. That is, λo(t) is the age-specific hazard rate for
individuals who do not carry a causal variant, i.e. sporadic
cases. Let λonset(t|x) denote the age-specific hazard rate
of disease for an individual aged t years conditioned on
rare-variant status such that
λonset(t|x) =
{
λo(t), if x = 0;
κ · λo(t), if x = 1,
for κ ≥ 1.
If pc is the carrier probability of all causal variants
considered as a group, then we can express the population
age-specific hazard rate of disease, λonset(t), as
λonset(t) = (1 − pc)λo(t) + κ · pc · λo(t).
Users are expected to provide λonset(t); given pc and κ we
infer λo(t) as λo(t) = λonset(t)1+pc(κ−1) . We note that this method
for calculating λo(t) has implications on the comparability
of non-genetic individuals from studies simulated under
very different κ values. For example, when pc is constant,
we see that for κ1 << κ2, the age-specific hazard rate
for non-carrier individuals under genetic relative-risk κ1
will be much greater than that of non-carrier individuals
under genetic relative-risk κ2. As pc increases this effect is
visible more quickly for differing κ values.
We note that not all individuals develop the disease;
however, those who do are only permitted develop the dis-
ease once in our model. Individuals who have developed
disease (i.e. δ = 1) do not develop disease again, but can
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reproduce or die. When δ = 0, we use intensity func-
tion λonset(t|x) conditioned on rare-variant status, x, to
simulate the waiting time to disease onset given current
age, t′. To clarify, if we denote the waiting time to disease
onset by Wonset , and condition on the current age, t′, the
cumulative distribution function ofWonset is given by









We model death using a non-homogeneous Poisson pro-
cess, conditioned on an individual’s current age, t′, and
disease status, δ. Define δ as in the previous discus-
sion, and let λu(t) and λa(t) denote the age-specific
hazard rates of death, for individuals aged t years, in
the unaffected population and the affected population,
respectively. We use intensity function λdeath(t|δ) condi-
tioned on disease status δ to simulate the waiting time to
death given the current age, t′. In this context, λdeath(t|δ)
represents the age-specific hazard rate of death for an
individual aged t years conditioned on their disease status,
which we model as
λdeath(t|δ) =
{
λu(t), if δ = 0;
λa(t), if δ = 1.
We do not model disease remission; after an individual
has developed disease we use the age-specific hazard rates
for death in the affected population to model their waiting
time to death.
Reproduction
To accommodate extra-Poisson variability in the number
of human offspring, we use a negative-binomial model
with number of trials n ≈ 2 and success probability p ≈
4/7, as proposed by [8]. We adopt this negative-binomial
model of offspring number in SimRVPedigree. We
employ an equivalent Poisson-Gamma mixture model [9]
to obtain the negative-binomial offspring number and to
simulate the waiting time to reproduction.
Letwt′ denote the waiting time to reproduction given an
individual’s current age t′, and assume that simulated sub-
jects are able to reproduce from age a1 to age a2. Tomimic
observed data on first-born live births (see Additional
file 1: Section 6), we simulate a1 and a2 as follows: sample
a1 uniformly from ages 16 to 27, and a2 − a1 uniformly
from 10 to 18 years. At birth we simulate an individual’s
lifetime birthrate by taking a random draw, γ , from a
gamma distribution with shape 2 and scale 4/3. Individu-
als who draw large γ will have high birth rates and many
children, whereas individuals who draw small γ will have
low birth rates and few or no children.
For some diseases, users may want to reduce the birth
rate after disease onset; we allow users to achieve this
through an additional parameter f, assumed to be between
0 and 1, which is used to rescale the birth rate after dis-
ease onset. By default, f = 1 so that the birth rate remains
unchanged after disease onset. Given an individual’s birth
rate, current age, and disease status, δ, we obtain their
waiting time to reproduction as follows:
1 Simulate the unconditional waiting time to
reproduction by drawing w from an exponential
distribution with rate γ f δ+γ (1−δ)
(a2−a1) .
2 Condition on the current age, t′, to obtain the




a1 + w − t′, if t′ < a1and (a1 + w) < a2;
t′ + w, if t′ ∈[a1, a2) and (t′ + w) < a2;
∞, otherwise.
Pedigree simulation
To simulate all life events for a subject, starting at birth we
generate waiting times to disease onset, death, and repro-
duction, as outlined previously and choose the event with
the shortest waiting time to be the next life event. Next,
we add the waiting time associated with the earliest event
to the current age and either record the year of disease
onset or death, or add a new offspring to the pedigree. We
repeat this process from the updated age, recursively, until
the individual dies or the study stop year is reached. This
algorithm details the full life event procedure at the indi-
vidual level. Complete details are available in Additional
file 1.
To simulate a full pedigree, we recursively apply the
algorithm described above, as follows:
• Step 1: Simulate life events for the first founder given
rare-variant status.
• Step 2: Simulate life events for any new offspring
given rare-variant status as outlined above.
• Step 3: Repeat step 2 until life events have been
simulated for all offspring.
Ascertainment features
Theprimary functionofSimRVPedigree,sim_RVped(),
simulates pedigrees ascertained formultiple disease-affected
relatives.We allow users to specify family-based study fea-
tures through the following arguments of sim_RVped():
num_affected: the minimum number of disease-
affected relatives required for ascertainment of the
pedigree.
ascertain_span: the start and stop year for pedigree
ascertainment.
stop_year: the last year of follow-up for the pedigree.
recall_probs: the proband’s recall probabilities for
relatives of varying degree.
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In this context, the proband is the affected family mem-
ber first in contact with the study, presumably at the time
of disease onset.
The ascertainment span represents the time span,
in years, over which the family could be ascertained
through the proband. For example, suppose that a par-
ticular study ascertained families, containing at least two
affected members, from 2000 to 2010. In this scenario,
the user would set ascertain_span= c(2000,
2010) and num_affected= 2. The sim_RVped()
function would then simulate families such that the
proband developed disease between 2000 and 2010 and
was at least the second family member to develop
disease.
The study stop year represents the last year data are
collected for ascertained families. Consider the previ-
ous study, and suppose that data were collected until
2016. To achieve this in simulation, users would sim-
ply specify stop_year = 2016, which would result
in sim_RVped() simulating life events for ascertained
families until the year 2016.
Often researchers involved in family-based studies are
confronted by incomplete ascertainment of a proband’s
relatives, which could occur if the proband cannot provide
a complete family history, or if he or she does not support
contact of specific relatives. SimRVPedigree allows
users to mimic this scenario, in simulation, by trim-
ming relatives from a pedigree based on the proband’s
probability of recalling them. To specify a proband’s recall
probabilities for his or her relatives, i.e. recall_probs,
the user provides a list of length q, such as
p = (p1, p2, ..., pq). In this context, pi is used to denote the
proband’s recall probability for a relative of degree i when
i = 1, 2, ..., q − 1, or the proband’s recall probability for
a relative of degree q or greater when i = q. To simulate
fully ascertained families, we set recall_probs =
c(1), which corresponds to p = 1. Alternatively, if
unspecified, recall_probs is set to four times the
kinship coefficient, e.g. [10]. This default value retains the
proband’s first-degree relatives (i.e. parents, siblings, and
offspring) with probability 1, second-degree relatives (i.e.
grandparents, grandchildren, aunts, uncles, nieces, and
nephews) with probability 0.5, third-degree relatives with
probability 0.25, etc.
In the event that a trimmed relative is required to fully
specify the relationships among recalled family mem-
bers, we include the trimmed relative, mark them as
unavailable, and remove (i.e. mark as missing) any of their
relevant information. That is, disease status, relative-risk
of disease, and event years are all missing for any rela-
tives not recalled by the proband. Since disease-affected
relatives may be trimmed from a pedigree, trimmed pedi-
grees may contain fewer than num_affected disease-
affected relatives. When this occurs, sim_RVped()
will discard the pedigree and simulate another until all
conditions specified by the user are met.
Results
Settings
In the following applications, we use SimRVPedigree
in conjunction with R [11] to investigate the effect of the
relative-risk of disease in genetic cases, κ , on ascertained
pedigrees. We first investigate the effect of κ on the num-
ber of affected relatives per family, and on the degree
of familial clustering among affected relatives. Next, we
investigate how ages of onset from more recent genera-
tions tend to be younger than those from older gener-
ations in the ascertained pedigrees [12], a phenomenon
which we refer to as apparent anticipation. Lastly, we
demonstrate how SimRVPedigree may be used to esti-
mate the proportion of families that segregate the causal
variant in a sample of ascertained pedigrees.
To study pedigrees ascertained to contain multiple rel-
atives affected by a lymphoid cancer, we simulated study
samples according to the following criteria.
1 Each study sample contained a total of one thousand
pedigrees, ascertained from the year 2000 to the year
2015.
2 Each pedigree contained at least two relatives
affected by lymphoid cancer.
3 The birth year of the founder who introduced the
rare variant to the pedigree was distributed
uniformly from 1900 to 1980.
4 For each κ considered, the carrier probability, pc, for
all causal variants with genetic-relative risk κ was
assumed to be 0.002.
5 Sporadic cases, i.e. affected individuals who did not
inherit the rare variant, develop lymphoid cancer
according to the baseline, age-specific hazard rate of
lymphoid cancer. The population, age-specific hazard
rate of lymphoid cancer were estimated through the
Surveillance, Epidemiology, and End Results (SEER)
Program [13, 14], and are displayed in Fig. 1.
6 Genetic cases, i.e. affected individuals who did inherit
the rare variant, develop lymphoid cancer at κ times
the baseline, age-specific hazard rate of lymphoid
cancer. We considered κ ∈ (1, 10, 20) and simulated
one thousand pedigrees for each κ considered.
7 Since lymphoid cancer accounts for a relatively small
proportion of all deaths, the age-specific hazard rate
for death in the unaffected population was
approximated by that of the general population.
Individuals who do not develop lymphoid cancer die
according to the age-specific hazard rate of death in
the general population [15], while individuals who
have developed lymphoid cancer die according to the
age-specific hazard rate of death in the affected
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Fig. 1 Hazard Rates. (Left) Baseline, age-specific hazard rates of lymphoid cancer estimated by SEER [13, 14]. SEER provides age-specific incidence and
morality data, in yearly increments, up to age 84 years, and then aggregates data for ages of 85 years or greater. We considered the SEER reported
incidence rate for individuals of age 85 or greater to be the constant hazard rate of disease for individuals between the ages of 85 to 100. (Right)
Age-specific hazard rates of death for the general population [15] and for the disease-affected population [13, 16, 17]. To promote continuity in the
age-specific hazard rate of death for the affected population, we assume that it is twice that of the unaffected population after age 84 years. After
age 84 years, the SEER data do not allow for the age-specific hazard rates of death in the affected population to be estimated in yearly increments
population [13, 16, 17]. Figure 1 displays the
age-specific hazard rates of death for these two
groups.
8 The proband’s probabilities for recalling relatives
were set to recall_probs = (1, 1, 1,
0.5, 0.125), so that all first, second, and
third-degree relatives of the proband were recalled
with probability 1, all fourth-degree relatives of the
proband were recalled with probability 0.5, and all
other relatives of the proband were recalled with
probability 0.125.
9 The stop year of the study was set to 2017.
Example
Wedemonstrate how to simulate a single pedigree accord-
ing to the settings described previously.
After installing SimRVPedigree, we load the package
in R using the library function.
R> library(SimRVPedigree)
Suppose that we can obtain age-specific hazard rates
in yearly increments starting at age 0 and ending with
age 100. In this case, we define the partition of ages over
which to apply the age-specific hazards rates using the
seq function.
R> age_part <- seq(0, 100, by = 1)
Next, assume that LC_Hazards is a data frame whose
columns provide age-specific hazard rates, in yearly
increments, from age 0 to age 100, as indicated below.
LC_Hazards[, 1] Age-specific hazard rates of lym-
phoid cancer in the general population.
LC_Hazards[, 2] Age-specific hazard rates of death
for individuals in the general population.
LC_Hazards[, 3] Age-specific hazard rates of death
for individuals who have lymphoid cancer.
We create a new object of class hazard from the par-
tition of ages, age_part, and the data frame of hazard
rates, LC_Hazards, by executing the following com-
mand.
R> haz_mat <- hazard(partition = age_part,
hazardDF = LC_Hazards)
To simulate a single pedigree with family identification
number 1 and a genetic relative-risk of 10, assuming that
the eldest founder introduces the variant, and according
to the settings described previously we use the following
command.
R> ex_ped <- sim_RVped(hazard_rates =
haz_mat, GRR = 10, FamID = 1,
num_affected = 2, RVfounder = TRUE,
ascertain_span = c(2000, 2015),
founder_byears = c(1900, 1980),
recall_probs = (1, 1, 1, 0.5, 0.125),
stop_year = 2017)




full_ped 15 ped list
ascertained_ped 15 ped list
Upon executing the command above, we see that
ex_ped is a list containing two objects of class ped.
The first is named full_ped and represents the orig-
inal pedigree, prior to proband selection and trimming.
The second is named ascertained_ped and repre-
sents the ascertained pedigree; this data frame includes an
additional variable to identify the proband. In this applica-
tion, we are interested in families that were ascertained for
study; hence, we focus attention on ascertained_ped.
To simplify the following examples, we store the ascer-
tained pedigree as study_ped.
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R> study_ped <- ex_ped$ascertained_ped
To plot the ascertained pedigree we simply supply the
pedigree to the plot function.
R> plot(study_ped)
The plotted pedigree is displayed in Fig. 2.
To obtain summary information for study_ped we





ave_onset_age ave_IBD asc_year seg_RV
52.5 0.333 2002 TRUE
$affected_info
FamID ID birthYr onsetYr
1 1 1911 1965
1 3 1933 2014
1 9 1966 2002
1 10 1972 2011
deathYr RR proband RVstatus
1968 10 FALSE 1
NA 1 FALSE 0
NA 10 TRUE 1
NA 10 FALSE 1
As displayed above, when the argument of summary
is an object of class ped, summary returns two data
frames named family_info and affected_info.
The family_info data frame catalogues the informa-
tion for the entire family. For each family supplied it
provides (from left to right): family identification num-
ber, the total number of relatives in the pedigree, the total
number of disease-affected relatives in the pedigree, the
average onset age of the disease-affected relatives, the
average of the pairwise probabilities of identity by descent
(IBD) among the disease-affected relatives in the pedi-
gree, the ascertainment year of the pedigree, and a logical
variable indicating whether or not the pedigree segre-
gates a casual variant. The affected_info data frame
catalogues information for the disease-affected relatives.
For each disease-affected relative it details (from left to
right): family identification number, individual identifica-
tion number, year of birth, year of disease-onset, year of
death, relative risk of disease, proband status, and rare
variant status.
Applications
Number of disease-affected relatives
To illustrate how the number of disease-affected rela-
tives in each pedigree varies with κ , we refer to the data
described in Settings. This data contains simulated study
samples, containing 1000 pedigrees, for κ = 1, κ = 10,
and κ = 20.
Figure 3 summarizes the distribution of the number
of disease-affected relatives per pedigree for these three
groups. From the figure we see that for κ = 1 this
distribution is more highly concentrated at two affected
members than for the other two groups considered. Not
Fig. 2 Simulated Pedigree. In this pedigree squares are used to symbolize males and circles are used to symbolize females. Mates are connected by a
horizontal line, and their offspring branch out below. Individuals who have died have a slash through their symbol. As indicated by the legend, if the
upper left third of an individual’s symbol is shaded black, then that individual is disease-affected. If the upper right third of an individual’s symbol is
shaded, then that individual is a carrier of the causal variant. If the bottom third of an individual’s symbol is shaded, then that individual is the proband
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Fig. 3 Bar charts of Number of Disease-Affected Relatives per Pedigree. Barcharts of number of disease-affected relative per pedigree grouped by
genetic relative-risk of disease, κ
surprisingly, as κ increases we see relatively fewer families
containing only two affected members, and more families
containing three or greater affected members.
Familial clustering
To investigate the relationship between familial cluster-
ing among affected relatives and κ , we restrict atten-
tion to pedigrees that contained two or three affected
relatives. We did not consider pedigrees with four or
more disease-affected relatives because these pedigrees
are rarely observed when κ = 1. This resulted in a total
of 999 simulated pedigrees in the κ = 1 group, 970
simulated pedigrees in the κ = 10 group, and 939 simu-
lated pedigrees in the κ = 20 group. To assess the level
of familial clustering among affected relatives, we com-
puted the average of the pairwise IBD probabilities among
affected members in a pedigree, which we will denote by
AIBD. AIBD is proportional to the genealogical index of
familiality statistic [18], which has been used to summa-
rize familial clustering of aggressive prostate cancer in the
Utah population. In general, the IBD probability between
two relatives decreases as they become more distantly
related. For example, for an affected parent-child pair, or
two affected siblings AIBD = 0.5; whereas for an affected
avuncular pair, or an affected grandparent-grandchild pair
AIBD = 0.25.
Figure 4 shows the conditional distribution of AIBD
given the total number of affected relatives in a pedi-
gree and κ . Tabulated results for Fig. 4 are available
in Additional file 1: Section 2. The left panel of Fig. 4
summarizes the conditional distribution of AIBD for fam-
ilies with two affected members. The conditional distri-
bution of AIBD shifts probability mass toward 0.5 as κ
increases and suggests that disease-affected individuals
tend to be more closely related in families with larger
values of κ . The right panel of Fig. 4 summarizes the con-
ditional distribution of AIBD among families with three
affected members, and shows the same trend as the left
panel, of AIBD values shifted towards 0.5 for larger values
of κ .
Anticipation
Anticipation is a decreasing trend in the age of disease
onset, and possibly an increasing trend in severity, in suc-
cessive generations of a family [19]. Some genetic diseases
with unstable repeat expansions show anticipation, and
include: Huntington’s Disease, fragile X syndrome, and
myotonic dystrophy [20].
However, studies of genetic anticipation based solely on
the ages of onset of affected members have the potential
for ascertainment bias [21]. Possible sources of ascer-
tainment bias include: early detection in offspring due
to parental diagnosis or improved diagnostic techniques
and right-censoring of family members who have devel-
oped the disease by the end of the study, especially in
studies of large multi-generational pedigrees that have
been ascertained to contain multiple affected members.
[12, 21].
Referring to the data described in section Settings,
we illustrate how apparent anticipation can arise as an
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Fig. 4 Bar charts ofAIBD Distributions. Barcharts ofAIBD distributions for pedigrees with two (left) or three (right) disease-affected relatives, grouped
by genetic relative-risk of disease
artefact of studies ascertaining families with multiple
disease-affected relatives. Within each of the families con-
sidered, generation number was assigned among affected
relatives so that generation number one represents the
most recent common ancestor with whom all affected
members could share a variant identical by descent. In this
assignment scheme, we allow an affected individual to be
his or her own most recent common ancestor. To demon-
strate this convention, consider a family with two affected
relatives: if the affected members are a parent-child pair,
then the parent would be assigned generation number
one, and the child assigned generation number two. How-
ever, if the affectedmembers are a sibling pair, each sibling
would be assigned generation number two, since a par-
ent is the closest relative from whom the affected siblings
could have inherited a disease variant.
Figure 5 displays the ages of onset, by assigned genera-
tion, grouped by κ , the relative-risk of disease for genetic
cases. We emphasize that SimRVPedigree does not
include a mechanism to simulate anticipation. However,
we note that even though anticipation is not present in
the simulated data, within each genetic-relative-risk group
considered, the box plots exhibit a decreasing trend in the
ages of onset for successive generations. The false antic-
ipation signal is likely due to many of the ascertained
pedigrees being large, and multi-generational, and there-
fore prone to right-censoring of younger family members
who will develop disease later in life, after the study stop
year.
If there is right-censoring of younger family members
then this censoring should be apparent in their ages of
death as well. Therefore it is useful to consider using the
ages of death in unaffected relatives as a negative con-
trol to gain insight into ascertainment bias [19]. Box plots
of the ages of death in unaffected relatives by genera-
tion for the relative-risk groups are similar to those in
Fig. 5 for the age of onset in disease-affected relatives. This
similarity strongly suggests the presence of ascertainment
bias. Further details of this investigation may be found in
Additional file 1: Section 3.
Proportion of ascertained pedigrees segregating a causal
variant
Familial lymphoid cancer, i.e. a family that contains multi-
ple relatives affected by lymphoid cancer, is relatively rare;
however, lymphoid cancer is not a rare disease as it affects
roughly 1 in 25 [13, 14]. With such diseases, there is a
greater risk of ascertaining pedigrees that contain multi-
ple disease-affected relatives by chance alone. Since we do
not expect these pedigrees to segregate a causal variant
it is advantageous to choose ascertainment criteria that
reduces the likelihood of sampling such pedigrees.
To determine what proportion of ascertained families
we expect to segregate a causal variant we conducted a
simulation study in which the rare variant status of the
starting founder was allowed to vary so that fully sporadic
pedigrees were given an opportunity for ascertainment.
The procedure to simulate a study containing both
genetic and sporadic families may be described as follows.
Step 1: Allow the starting founder to introduce a causal
variant with genetic relative-risk κ with probability
0.002.
Step 2: Simulate the rest of the pedigree, according to
the settings described in Settings, and add it to our
sample of ascertained pedigrees if it meets the ascer-
tainment criteria.
Step 3: Repeat steps one and two until the requisite num-
ber of pedigrees have been ascertained.
For this procedure we considered κ = 1 and all multiples
of 5 between 5 and 100, i.e. κ ∈ (1, 5, 10, 15, . . . , 95, 100).
For each κ considered we simulated a family study
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Fig. 5 Box plots of Age of Disease Onset by Assigned Generation Number. Boxplots of age of onset by assigned generation number, as defined in text,
grouped by genetic relative-risk of disease, κ . The numbers of observations, n, used to create each box plot are displayed above their respective plots
containing one thousand ascertained pedigrees. Next, we
determined what proportion of the ascertained pedigrees
were segregating a causal variant that increased disease
susceptibility. The results of this investigation are dis-
played in Fig. 6. The leftmost panel in Fig. 6 indicates
that most of the ascertained pedigrees are not segregating
a causal variant. For example, when the genetic relative-
risk is 20, we see that less than 20% of the ascertained
pedigrees with two or more disease-affected relatives are
segregating a causal variant. Focusing attention on the
ascertained pedigrees that contain three or more affected
relatives (themiddle panel of Fig. 6) we see that these pedi-
grees tend to segregate a causal variant more often than
the pedigrees that only contained two or more affected
relatives. When we restrict our focus to the ascertained
pedigrees that contain four or more affected relatives
(the rightmost panel of Fig. 6), we see more of these
pedigrees tend to segregate a causal variant. These esti-
mates tend to be more erratic because we don’t often
observe fully sporadic families with four or more affected
relatives. Among the original samples of one thousand
pedigrees, we observe only two fully sporadic pedigrees
with five affected relatives, and none with six or more
disease-affected relatives.
These results indicate that when a disease is not
rare, and when the carrier probability of the causal
variant is very low (i.e. pc = 0.002), focusing
on families with at least three affected relatives is
more effective for sampling pedigrees that segre-
gate a causal variant. Focusing on pedigrees with
Fig. 6 Genetic Contribution Estimate. Scatter plots of the probability that a randomly selected pedigree from a sample of ascertained pedigrees is
segregating a genetic variant with relative-risk of disease κ against the relative-risk of disease κ . Here we consider the effect of restricting attention
to the ascertained pedigrees with nA or more disease-affected relatives. In the leftmost panel, we consider all one thousand pedigrees ascertained
with two or more disease-affected relatives; in the middle panel, we consider the subset with three or more disease-affected relatives, and in the
right most panel the subset with four or more disease-affected relatives
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at least four affected relatives provides even greater
improvement.
Computation time
Wewould like to note that simulation of ascertained pedi-
grees can be computationally expensive. Therefore, we
urge users to take advantage of parallel processing, in R,
or cluster computing when simulating a large number of
ascertained pedigrees.
There are several factors that effect the amount of time
required to simulate a pedigree. For example, the genetic
relative-risk, the probability that a causal rare variant is
segregating in the family, and the ascertainment span, to
name a few. To illustrate the effect of the genetic relative-
risk on timing we consider the family-study described in
Settings. The following table provides summary statistics
for the average computation time, in seconds, required to
simulate a single pedigree on a Windows OS with an i7-
4790@ 3.60 GHz, 12 GB of RAM, and a C220 SATAAHCI
(Table 1).
When probability that a causal rare variant is segregat-
ing in the family is small, the simulation time will tend
towards the time required to simulate an ascertained pedi-
gree with a genetic relative-risk of 1. This is the case for all
pedigrees simulated in Proportion of ascertained pedigrees
segregating a causal variant since the probability that the
eldest founder introduces the rare variant is 0.002.
Discussion
We provide several applications for SimRVPedigree to
illustrate the effect of the genetic relative-risk, κ , on fea-
tures of the ascertained pedigrees. First, we investigate the
relationship between κ and the number of affected indi-
viduals in each ascertained family. In this application, as
κ increases we observe pedigrees that contain three or
more affected relatives more frequently than pedigrees
with only two affected relatives.
Second, we examine the relationship between κ and the
average, pairwise IBD probability among affected relatives
in a pedigree. We observe that pedigrees simulated with
larger values of κ tend to contain affected relatives that
are more closely-related than pedigrees simulated with
smaller values of κ .
Table 1 Comparison of Computation Time for Various Genetic
Relative-Risk Values
Standard deviation
Genetic Average simulation of simulation time Number
relative-risk time (in seconds) (in seconds) of trials
1 30.752 32.539 50
10 1.461 1.339 50
20 0.650 0.564 50
Tabulated average computation time and standard deviation of computation time,
in seconds. These results were obtained over 50 repeated simulations of a single
pedigree
Third, we illustrate that the family-based study design
can contribute to apparent anticipation signals. In part,
this is due to large, multi-generational pedigrees, which
are prone to right-censoring of younger family members
likely to experience disease onset later in life. This type
of right-censoring can confound true genetic anticipation.
We observe that it is possible to reduce this bias by follow-
ing family members available at the time of ascertainment
for a sufficient length of time. However, the necessary time
frame (roughly 100 years) is impractical for real studies
[see Additional file 1: Section 4].
Finally, we show how users can estimate the propor-
tion of ascertained pedigrees that are segregating a variant
that increases disease susceptibility. In this application we
find that when the carrier probability of all causal vari-
ants considered as a group is 0.002, many of the pedigrees
ascertained with two or more disease-affected relatives do
not segregate a genetic variant. In this scenario, it may
be advantageous for researchers to focus on pedigrees
with three or more disease-affected relatives. We note
that when the carrier probability increases results will
vary [see Additional file 1: Section 5]. SimRVPedigree
is intended for simulating diseases that are influenced
by rare variants (e.g. allele frequency < 0.005); however,
when the carrier probability is increased to reflect vari-
ants that are less rare (e.g. allele frequency ∈[ 0.005, 0.01]),
SimRVPedigree may underestimate the proportion of
ascertained pedigrees that contain genetic cases.
We emphasize that ascertained families can differ sub-
stantially depending on the simulation settings chosen.
For example, variations in the ascertainment span can
affect the distribution of the number of affected relatives
in each pedigree, when all other study settings remain
constant.
Conclusions
The SimRVPedigree package provides methods to sim-
ulate pedigrees that contain multiple disease-affected rel-
atives ascertained by a family-based study. To simulate life
events at the individual level, SimRVPedigree models
disease onset, death, and reproduction as competing life
events; thus, pedigrees are shaped by the events simu-
lated at the individual level. SimRVPedigree allows for
flexible modelling of disease onset through user-supplied
age-specific hazard rates for disease onset and death, and
also permits flexibility in family-based ascertainment.
Among their benefits, family-based studies of large
pedigrees with multiple disease-affected relatives enjoy
increased power to detect effects of rare variants [2].
However, to conduct a family-based study of a rare dis-
ease it may take years to collect enough data. For planning
and inference, we present the SimRVPedigree package
to readily simulate pedigrees ascertained for multiple rel-
atives affected by a rare disease. To our knowledge, this
is the first package to dynamically simulate pedigrees to
account for competing life events.
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Additional file
Additional file 1: SimRVPedigree Supplement. This is a pdf file that
provides detailed information about the simulation procedure, as well as
additional information for the applications discussed in the main text.
(PDF 254 kb)
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